NCT06398418 R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors Status RECRUITING Phase PHASE1
NCT06384417 Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 Status ACTIVE_NOT_RECRUITING Phase NA
NCT06365619 Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma Status RECRUITING Phase PHASE2
NCT06362369 A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy Status RECRUITING Phase PHASE1/PHASE2
NCT06327698 Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure Status NOT_YET_RECRUITING Phase PHASE2
NCT06326411 A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors Status RECRUITING Phase PHASE1
NCT06321640 Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies. Status RECRUITING Phase N/A
NCT06305247 A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06295159 Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma Status RECRUITING Phase PHASE2
NCT06287463 Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway Status TERMINATED Phase PHASE1
NCT06285097 A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT06281678 A Study of IBI363 in Subjects with Advanced Solid Malignancies Status RECRUITING Phase PHASE2
NCT06254196 Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies Status RECRUITING Phase NA
NCT06246916 A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) Status RECRUITING Phase PHASE3
NCT06246227 ctDNA for Early Detection of Recurrence in Melanoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06242470 A Study of MGC026 in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06240143 Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma Status RECRUITING Phase PHASE1/PHASE2